Cargando…

Impact of inflammation and immunotherapy in renal cell carcinoma

Substantial research attention has been directed at exploring the mechanisms and treatment of renal cell carcinoma (RCC). Indeed, the association between inflammation and tumor phenotypes has been at the center of cancer research. Concomitant with research on the inflammation response and inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jian, Wang, Keshan, Xiong, Zhiyong, Yuan, Changfei, Wang, Cheng, Cao, Qi, Yu, Huang, Meng, Xiangui, Xie, Kairu, Cheng, Zhixian, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520756/ https://www.ncbi.nlm.nih.gov/pubmed/33014151 http://dx.doi.org/10.3892/ol.2020.12135

Ejemplares similares

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress
por: Shi, Jian, et al.
Publicado: (2021)

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
por: Meng, Xiangui, et al.
Publicado: (2020)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020)

NNT‐induced tumor cell “slimming” reverses the pro‐carcinogenesis effect of HIF2a in tumors
por: Xiong, Zhiyong, et al.
Publicado: (2021)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2019)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2022)

Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
por: Xie, Kairu, et al.
Publicado: (2021)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia
por: Hu, Wenjun, et al.
Publicado: (2021)

Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress
por: Xiong, Zhiyong, et al.
Publicado: (2020)

Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis
por: Feng, Chunxiang, et al.
Publicado: (2020)

The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling
por: Shi, Jian, et al.
Publicado: (2023)

The screening of pivotal gene expression signatures and biomarkers in renal carcinoma
por: Ruan, Hailong, et al.
Publicado: (2019)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2017)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
por: Wang, KeShan, et al.
Publicado: (2019)

Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT
por: Xu, Ning, et al.
Publicado: (2022)

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma
por: Li, Weiquan, et al.
Publicado: (2022)

Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma
por: Meng, Xiangui, et al.
Publicado: (2021)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway
por: Miao, Daojia, et al.
Publicado: (2023)

A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma
por: Cheng, Gong, et al.
Publicado: (2019)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress
por: Yuan, Hongwei, et al.
Publicado: (2023)

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
por: Wang, Keshan, et al.
Publicado: (2018)

Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-κB signaling pathway
por: Xiong, Hairong, et al.
Publicado: (2022)

Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape: DDR inhibitors, radiotherapy and immunotherapy can kill cancer cells
por: Qiu, Yuyue, et al.
Publicado: (2022)

A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma
por: Wei, Zhihao, et al.
Publicado: (2022)

Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a
por: Liu, Hailang, et al.
Publicado: (2021)

High SAA1 Expression Predicts Advanced Tumors in Renal Cancer
por: Li, Sen, et al.
Publicado: (2021)

Immunotherapy for Renal Cell Carcinoma
por: Itsumi, Momoe, et al.
Publicado: (2010)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
por: Li, Mengyuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1500cfq916ml4qfmif5lonu6cu